Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Serfaty

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
Management of patients with non-alcoholic steatohepatitis (NASH) in real lifeLawrence Serfaty
Clinics in Liver Disease|July 11, 2017
Metabolic Manifestations of Hepatitis C Virus: Diabetes Mellitus, DyslipidemiaLawrence Serfaty
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
How to optimize current therapy in hepatitis C virus genotype 1 patients. Predictors of response to interferon-based therapy with second wave direct acting antiviralsLawrence Serfaty
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
Is there still a role for PEG IFN+RBV therapy in patients with HCV genotype 1?Lawrence Serfaty
Journal of Hepatology|May 1, 2007
Pioglitazone: the beginning of a new era for NASH?Lawrence Serfaty
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2016
Follow-up of patients with chronic hepatitis C and a sustained viral responseLawrence Serfaty
Clinics and Research in Hepatology and Gastroenterology|November 13, 2012
Chemoprevention of colorectal cancer with ursodeoxycholic acid: proLawrence Serfaty
Gastroenterologie Clinique Et Biologique|August 16, 2002
[Treatment of patients with chronic hepatitis C virus infection and normal transaminases]Lawrence Serfaty
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 5, 2013
Optimizing DAA management in daily practiceLawrence Serfaty
Gastroenterology|February 14, 2016
Clinical Implications of Concomitant Alcohol Use, Obesity, and Viral HepatitisLawrence Serfaty
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
Management of patients with non-alcoholic steatohepatitis (NASH) in real lifeLawrence Serfaty
Clinics in Liver Disease|July 11, 2017
Metabolic Manifestations of Hepatitis C Virus: Diabetes Mellitus, DyslipidemiaLawrence Serfaty
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
How to optimize current therapy in hepatitis C virus genotype 1 patients. Predictors of response to interferon-based therapy with second wave direct acting antiviralsLawrence Serfaty
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
Is there still a role for PEG IFN+RBV therapy in patients with HCV genotype 1?Lawrence Serfaty
Journal of Hepatology|May 1, 2007
Pioglitazone: the beginning of a new era for NASH?Lawrence Serfaty
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2016
Follow-up of patients with chronic hepatitis C and a sustained viral responseLawrence Serfaty
Clinics and Research in Hepatology and Gastroenterology|November 13, 2012
Chemoprevention of colorectal cancer with ursodeoxycholic acid: proLawrence Serfaty
Gastroenterologie Clinique Et Biologique|August 16, 2002
[Treatment of patients with chronic hepatitis C virus infection and normal transaminases]Lawrence Serfaty
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 5, 2013
Optimizing DAA management in daily practiceLawrence Serfaty
Gastroenterology|February 14, 2016
Clinical Implications of Concomitant Alcohol Use, Obesity, and Viral HepatitisLawrence Serfaty
Pageof 14